Down Syndrome
📧 Sign up to get email alerts when something new happens for Down Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-02Clinical Trial Update: Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome [Phase 2]
A Phase 2 trial evaluating GM-CSF (sargramostim) for Down syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Physiological Abnormalities Associated with Down Syndrome
The clinical trial NCT03087500 investigating physiological abnormalities associated with Down syndrome has been withdrawn.